Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Operative Analgesia After Third Molar Extraction
NCT06484439Phase 1Completed
- Sponsor
- Naval Medical Center San Diego
- Start
- Feb 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketorolac in postoperative pain (2 arms), sponsored by Naval Medical Center San Diego. Primary endpoints: Post operative pain control at 5 days, Post operative opioid use at 5 days and 2 more. Started Feb 2018; status: completed.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06484439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06484439.